Vivani Medical, Inc. earnings releases VANI

Vivani Medical, Inc. last reported quarterly results on Aug 13, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): diluted EPS of -$0.07. It usually reports 36–44 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 12, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 36–44 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 13, 2026
44 days after quarter end
Q2 FY2026
ended Jun 30, 2026
—
-6
+10.8%
-0.07
+41.7%
May 13, 2026
43 days after quarter end
Q1 FY2026
ended Mar 31, 2026
—
-7
-7.6%
-0.08
+27.3%
Nov 13, 2025
44 days after quarter end
Q3 FY2025
ended Sep 30, 2025
—
-7
-8.1%
-0.11
+0.0%
Aug 5, 2025
36 days after quarter end
Q2 FY2025
ended Jun 30, 2025
0
-7
-33.4%
-0.12
-20.0%
May 13, 2025
43 days after quarter end
Q1 FY2025
ended Mar 31, 2025
0
-6
-4.4%
-0.11
Mar 13, 2025
72 days after quarter end
Q4 FY2024
ended Dec 31, 2024
0
-6
-0.4%
-0.11
Nov 13, 2024
44 days after quarter end
Q3 FY2024
ended Sep 30, 2024
0
-6
+10.9%
-0.11
+15.4%
Aug 13, 2024
44 days after quarter end
—
ended Jun 30, 2024
—
—
—

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
VANI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Alameda, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1266806
Former names
SECOND SIGHT MEDICAL PRODUCTS INC (until Aug 18, 2022); SECOUND SIGHT MEDICAL PRODUCTS INC (until Oct 10, 2003)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.